Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/28/1999 | US5959075 Testis-specific insulin homolog polypeptides |
09/28/1999 | US5958975 Antiodor, antimicrobial and preservative compositions and methods of using same |
09/28/1999 | US5958941 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs |
09/28/1999 | US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
09/28/1999 | US5958909 Insulinotropic hormones and uses thereof |
09/28/1999 | US5958907 Pharmaceutical compositions and uses of inorganic pyrophosphates |
09/28/1999 | US5958902 Method and composition for treating sleep apnea |
09/28/1999 | US5958893 Dna molecule |
09/28/1999 | US5958892 2-methoxyestradiol-induced apoptosis in cancer cells |
09/28/1999 | US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation |
09/28/1999 | US5958887 Use of a hymenoptera venom for the manufacture of a medicament for treating DNA virus infections |
09/28/1999 | US5958886 Carnitine-containing peptides and a method for using the same |
09/28/1999 | US5958885 Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood |
09/28/1999 | US5958884 Compositions and methods for treating erectile dysfunction |
09/28/1999 | US5958883 For preventing or treating alzheimer's disease, comprising administering to a subject in need thereof a peptide within an amyloid protein associated with alzheimer's disease |
09/28/1999 | US5958882 Compounds that inhibit T cell proliferation and methods using the same |
09/28/1999 | US5958881 Comprising peptide having amino acid sequence of vasoactive intestinal peptide; for inducing temporary substantial paralysis an area of interest in patients undergoing endoscopy or other medical procedure; side effect reduction |
09/28/1999 | US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof |
09/28/1999 | US5958879 Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal |
09/28/1999 | US5958877 Method for counteracting vasospasms, ischemia, renal failure, and treating male impotence using calcitonin gene related peptide |
09/28/1999 | US5958876 Cyclosporin-containing pharmaceutical compositions |
09/28/1999 | US5958874 Recombinant fibronectin-based extracellular matrix for wound healing |
09/28/1999 | US5958873 Oral formulation for treatment of bacteria-induced diseases of the colon |
09/28/1999 | US5958872 Active survival domains of IGF-IR and methods of use |
09/28/1999 | US5958772 Antisense inhibition of cellular inhibitor of apoptosis-1 expression |
09/28/1999 | US5958771 Oligonucleotide from 8 to 30 nucleotides in length; for diagnosis and therapy; antitumor/antiinflammatory agents |
09/28/1999 | US5958770 Glycoalkaloids |
09/28/1999 | US5958769 Compositions and methods for mediating cell cycle progression |
09/28/1999 | US5958768 Compositions for the treatment and diagnosis of infections of rev-binding primate lentiviruses are provided. the primate lentiviruses, including human immunodeficiency virus (hiv) type 1 (hiv-1), and type 2 (hiv-2) and siv are genetically, |
09/28/1999 | US5958765 For producing human monoclonal antibodies which are specific to respiratory syncytial virus and in particular the rsv fusion (f) protein |
09/28/1999 | US5958753 Nucleic acid sequences encoding Bau, a Bin1 interacting protein, and vectors and host cells containing same |
09/28/1999 | US5958750 Purified polynucleotide encoding a novel human hyaluronidase polypeptide; expression vectors and transformed host cells for the production of the polypeptide |
09/28/1999 | US5958746 Electron transport proteins |
09/28/1999 | US5958737 Single-chain β subunit dimers of the glycoprotein hormones and recombinant materials related thereto |
09/28/1999 | US5958736 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
09/28/1999 | US5958735 Polynucleotides encoding urogenital sinus derived growth inhibitory factor and vectors |
09/28/1999 | US5958732 Anticoagulants in snake venom |
09/28/1999 | US5958731 Cell junction PDZ protein |
09/28/1999 | US5958729 7-transmembrane receptor (a g-protein coupled receptor) identified as a human g-protein pituitary adenylate cyclase activating polypeptide (pacap)-like receptor for amnesiac like neuropeptides, referred to as ?hcegh45?; alzheimer's |
09/28/1999 | US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases |
09/28/1999 | US5958725 Human DP1 homolog |
09/28/1999 | US5958723 DNA encoding prostaglandin receptor DP |
09/28/1999 | US5958720 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
09/28/1999 | US5958712 Identifying altered t cell receptor ligand comprising major histocompatible complex and peptide that inhibits t cell effector response |
09/28/1999 | US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder |
09/28/1999 | US5958710 The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and |
09/28/1999 | US5958709 Processes for identifying compounds that bind to the human Y4 receptor |
09/28/1999 | US5958708 The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy. |
09/28/1999 | US5958699 Hybridization probe comprising polynulceotide encoding polypeptide; for identifying and encoding nucleic acid and amino acid sequences and using them for diagnosis, prevention, and treatment of intestinal diseases including cancer |
09/28/1999 | US5958697 Isolated nucleic acids encoding CYP7 promoter-binding factors |
09/28/1999 | US5958690 Human TSC--22 Homolog |
09/28/1999 | US5958685 Sequence encoding thr replaced by sequence encoding ala |
09/28/1999 | US5958683 Screening method using the RZR receptor family |
09/28/1999 | US5958682 Virus-directed enzyme prodrug therapy for treating tumor cells consisting of a viral vector encoding bacterial nitroreductase capable of converting a prodrug into a cytotoxic drug operably linked to a promoter; and the prodrug |
09/28/1999 | US5958678 A single-stranded nucleic acid molecule which encodes an amino acid sequence comprising at least a portion of a t4 glycoprotein is provided. |
09/28/1999 | US5958671 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
09/28/1999 | US5958457 Compositions for the delivery of antigens |
09/28/1999 | US5958442 Oncostatin M for treating inflammation |
09/28/1999 | US5958441 Devices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith |
09/28/1999 | US5958428 Synthetic compounds and compositions with enhanced cell binding |
09/28/1999 | US5958425 Viral vaccines |
09/28/1999 | US5958424 Recombinant chicken anemia virus particle |
09/28/1999 | US5958422 Containing a foreign peptide insert in the coat protein of the virus; for use in vaccines |
09/28/1999 | US5958416 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
09/28/1999 | US5958415 Protein allergen of Derf II and composition |
09/28/1999 | US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression |
09/28/1999 | US5958411 Methods of inhibiting ECM accumulation in the CNS by inhibition of TGF-β |
09/28/1999 | US5958409 Administering antitumor necrosis factor antibody to the human suffering with multiple sclerosis |
09/28/1999 | US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance |
09/28/1999 | US5958407 Ileus treatment method |
09/28/1999 | US5958406 Acne treatment with multifunctional enzyme |
09/28/1999 | US5958405 Human protein tyrosine kinase |
09/28/1999 | US5958404 Grafting cells for treatment of disease and diabetes |
09/28/1999 | US5958403 Localized immunosuppression by insertion of nucleic acid sequence encoding cytotoxic t-cell lymphocyte antigen-immunoglobulin operably linked to promoter into an islet cell, ex vivo |
09/28/1999 | US5958402 Antitumor therapy using ovine or bovine interferon-tau |
09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
09/28/1999 | US5958384 Use of emu oil for stimulating skin and hair growth |
09/28/1999 | US5958378 High dose liposomal aerosol formulations containing cyclosporin A or budesonide |
09/28/1999 | CA2187803C Methods of treating disease using sertoli cells and allografts or xenografts |
09/28/1999 | CA2076678C Improved chimeric toxins |
09/27/1999 | CA2227425A1 Cell-based gene therapy |
09/26/1999 | CA2264260A1 Polynucleotide molecules encoding neospora proteins |
09/24/1999 | CA2249660A1 Novel compounds |
09/23/1999 | WO1999047925A2 Methods and compositions for diagnosis of rheumatoid arthritis |
09/23/1999 | WO1999047708A1 Antisense modulation of pecam-1 |
09/23/1999 | WO1999047707A1 Antisense modulation of lfa-3 |
09/23/1999 | WO1999047697A1 Novel molecules of the g protein-coupled heptahelical receptor superfamily and uses therefor |
09/23/1999 | WO1999047680A1 Mutant recombinant allergens |
09/23/1999 | WO1999047678A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
09/23/1999 | WO1999047677A2 Polypeptides homologous to vegf and bmp1 |
09/23/1999 | WO1999047676A1 Human leupaxin polypeptide and dna encoding it, their uses |
09/23/1999 | WO1999047675A1 Mu-1, member of the cytokine receptor family |
09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
09/23/1999 | WO1999047673A2 Isolated mammalian membrane protein genes and related reagents |
09/23/1999 | WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
09/23/1999 | WO1999047670A1 Mammalian sodium channel proteins |
09/23/1999 | WO1999047669A2 Human nucleic acid sequences from tissue of breast tumors |
09/23/1999 | WO1999047668A2 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances |
09/23/1999 | WO1999047666A1 Human ci-mnll homolog gene: cbfbmd04 |